Alzai Health (TSXV:ALZI) Beneish M-Score


TSXV:ALZI Alzai Health Corp TSXV:ALZI
9 GF Score
Price C$0.50
! 1 Warning Sign
View Full Analysis

What is Alzai Health Beneish M-Score?

Alzai Health does not have enough data to calculate Beneish M-Score.

Alzai Health Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Alzai Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzai Health Beneish M-Score Chart

Alzai Health Annual Data
Trend
Beneish M-Score

Alzai Health Quarterly Data
Jan25 Apr25 Jul25 Oct25 Jan26
Beneish M-Score 0.00 0.00 0.00 0.00 0.00

TSXV:ALZI vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Alzai Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzai Health Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzai Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Alzai Health's Beneish M-Score falls into.


TSXV:ALZI
9GF Score
Alzai Health Corp TSXV:ALZI
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzai Health Business Description

Address 22 Adelaide Street West, Suite 3400, Toronto, ON, CAN, M5H 4E3
Alzai Health Corp is a healthcare company focused on comprehensive health solutions. It is an AI-driven Alzheimer's disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company uses low-cost, non-invasive, pre-existing biomarker data present in nearly all Electronic Medical Records of the relevant age demographic. It aims to address the unmet need in Alzheimer's screening, enabling early detection and mitigation driving to diagnosis, therapy or prevention.
9GF Score

Get the complete analysis for TSXV:ALZI

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price